科研之友
微信
新浪微博
Facebook
分享链接
摘要
Background: The vaccine industry is one of the most important health-related industries. It can be affected by accession to the World Trade Organization (WTO) because of probable dramatic changes in the business environment. Iran has already initiated accession negotiations. %26lt;br%26gt;Purpose of the study: In this paper, we investigate the position of, challenges to, and opportunities for vaccine manufacturing in Iran with regard to accession to the WTO. %26lt;br%26gt;Methods: This is a qualitative and cross sectional study. To collect information, we designed a questionnaire and interviewed some of the vaccine industry%26apos;s key opinion leaders in Iran. Before the interviews were conducted, the questionnaires were sent to these individuals by email. %26lt;br%26gt;Results: According to the interviewees, the country%26apos;s main challenges with regard to accession to the WTO are the lack of firm internal intellectual property (IP) rules, not being recognized as pre-qualified by the World Health Organization (WHO), the use of old equipment, and a lack of cooperation with global vaccine companies. %26lt;br%26gt;Major conclusions: Iran%26apos;s local vaccine industry, with a long history and international reputation that could be used as an advantage, is faced with several challenges, such as problems with keeping up with Current Good Manufacturing Practice (cGMP), a lack of adequate and meaningful investment in research and development (R%26D), and limitations on private sector participation in the production of vaccines. %26lt;br%26gt;Gradual privatization of the industry, improved international relations, utilization of the R%26D power of small hi-tech companies, consistent education of human resources, and modernization of infrastructures and equipment are among the suggested solutions.
- 出版日期2012-8-30
